Photo: (left to right) David Arons, NBTS; Sally Wills, Cushman & Wakefield; Jeff Kolodin, NBTS; Max Wallace, ABC2
WASHINGTON, D.C. − On Sunday May 5th, the 22nd annual Race for Hope – DC, presented by Cushman & Wakefield, brought together nearly 8,000 brain cancer advocates raising more than $1.7 million to benefit Accelerate Brain Cancer Cure (ABC2) and the National Brain Tumor Society (NBTS).
These organizations, as well as all of the participants, survivors and volunteers, share the hope for a day when a cure for brain tumors exists. Since its inception 22 years ago, the Race for Hope - DC has raised over $32 million for brain tumor research and support for those affected by the disease.
“Everyone who participates in the Race for Hope is making powerful and lasting contribution to brain tumor research and our community,” said Max Wallace, CEO of ABC2. “We’re proud to partner with the National Brain Tumor Society on this national event. The funds raised here help ABC2 advance effective new treatments for brain cancer patients that would not move forward without our investment.”
"Race for Hope is an inspirational event that kick-starts Brain Tumor Awareness Month every May and generates positive momentum for the remainder of the month, and indeed, the whole year," said David Arons, chief executive officer of the National Brain Tumor Society. "Thousands of people who are affected by brain tumors come together at Race for Hope to honor, remember, and celebrate survivorship as well as raise resources to help find a cure."
“Race for Hope has been extremely personal to the Cushman & Wakefield family ever since the loss of Pat Cassidy in 2001 and we are proud to have sponsored the event for the past 20 years in his honor,” said Peter Carroccio, Managing Principal of Cushman & Wakefield’s Washington, DC Metro Region. “We are honored to support the efforts of ABC2 and the National Brain Tumor Society and all they do to find a cure for brain cancer, while supporting patients and their families.”
Highlights of the 22nd annual Race for Hope - DC included a Survivor Tribute, led by Honorary Race Chair David Cook, featuring more than 300 brain tumor survivors who marched together towards the start line as a symbol of hope and strength in their battle against brain tumors. The Race for Hope - DC is the culmination of a weekend of activities, including many team-sponsored fundraising parties. These activities provide an opportunity for family and friends to honor and celebrate the lives of their loved ones, as well as provide support to each other.
During the awards ceremony, Cushman & Wakefield was honored for its 20 years of corporate leadership and title sponsorship of the race. The ceremony also featured a memorial tribute to Lionel Chaiken, a founder of the Race for Hope, who passed away last December at the age of 89. “We will miss Lionel dearly for his compassion, his humor, and his relentless drive to raise funds and awareness to improve the lives of brain tumor patients,” said Nike Beddow, Race Co-founder. “He was our true leader and champion of the Race for Hope.”
Top sponsors include: Cushman & Wakefield, Holliday, Fenoglio and Fowler and the Conley Family; Cravath, Swaine & Moore LLP; R&R Mechanical; Valero Energy; The Case Foundation; CoStar Group; Normandy Real Estate Partners; Urban Country; and 94.7 The Drive.
Each year, the Race for Hope – DC helps to bring hope and attention to this often underserved brain tumor community. The need to increase research funding is more urgent than ever – there are almost 700,000 people living with a primary brain tumor diagnosis in the U.S. and within the next 12 months, more than 210,000 people in the United States will be diagnosed with a primary or metastatic brain tumor.
About ABC² (Accelerate Brain Cancer Cure)
ABC² is focused on speeding the discovery of a cure for brain cancer. By applying an aggressive, venture funding approach not typically seen in the nonprofit sector, ABC² closes current gaps in funding in order to catalyze research and rapidly bring new therapies to patients. ABC² has awarded more than 100 grants totaling $21 million in brain tumor research funding to highly qualified investigators and physician-scientists from 54 institutions and companies. Since its founding in 2001, ABC2 has helped bring 30 different treatments into the clinic. To learn more, visit www.abc2.org.
About National Brain Tumor Society
National Brain Tumor Society is the largest nonprofit organization dedicated to the brain tumor community in the United States. We are in the unique position to affect change across the drug development, policy and legislative, research, and clinical trial systems at all levels. We don’t focus on a single method or approach to defeating brain tumors. We drive a multi-faceted and thoughtful approach to aggressively influence and fund strategic research and discovery, as well as advocate for public policy changes, in order to achieve the greatest impact, results, and progress for brain tumor patients. To learn more, visit www.braintumor.org.
About Cushman & Wakefield
Cushman & Wakefield is a leading global real estate services firm that helps clients transform the way people work, shop, and live. Our 45,000 employees in more than 70 countries help occupiers and investors optimize the value of their real estate by combining our global perspective and deep local knowledge with an impressive platform of real estate solutions. Cushman & Wakefield is among the largest commercial real estate services firms with revenue of $6 billion across core services of agency leasing, asset services, capital markets, facility services (C&W Services), global occupier services, investment & asset management (DTZ Investors), project & development services, tenant representation, and valuation & advisory. 2017 marks the 100-year anniversary of the Cushman & Wakefield brand. 100 years of taking our clients’ ideas and putting them into action. To learn more, visit www.cushwakecentennial.com, www.cushmanwakefield.com or follow @CushWake on Twitter.